Data Bridge Market Research analyses that the single lead electrocardiogram (ECG) equipment market which was USD 337.08 million in 2021, is expected to USD 620.74 million by 2029, at a CAGR of 5.22% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-single-lead-ecg-equipment-market
The purpose of single lead electrocardiogram (ECG) or single lead electrocardiogram (ECG) equipment is to measure the electrical activity of the heartbeat or to monitor heart rate. The global single lead ECG equipment market is likely to grow substantially in the coming years due to its growing application in sports activities and monitoring heart rating during exercise.
Key Growth Drivers:
- Rising single lead electrocardiogram equipment
The factors driving the growth of the single lead electrocardiogram equipment market in the forecast period of 2022 to 2029 is the expansion of its application scope in sports activities, monitoring heart rate during exercise, rising preference for cardiac assessment during self-triaging before using complex systems, and rising importance of homecare.
Furthermore, expanding RD efforts undertaken by multiple manufacturers will further encourage a number of new prospects that will fuel the expansion of the single lead electrocardiogram (ECG) equipment market during the forecast period.
- Research and development activities
Portable single-lead electrocardiogram devices that are useful for diagnosing arrhythmias, syncope, or assessing risks that may result in cardiovascular problems have developed as a result of ongoing research and development. For instance, patients with diabetes, hypertension, hypercholesterolemia, and obesity can utilise Omron Corporation's HeartScan ECG Monitor to determine their risk of CVD. These all are some of the factors which propel the growth of market.
The report outlines the involvement of key players, including:
Perlong Medical Equipment Co., Ltd (China), Ambisea Technology Corp., Ltd (China), Qardio Inc. (U.S.), Dimetek Digital Medical Technologies, Ltd (China), AliveCor, Inc. (U.S.), SUZUKEN CO., LTD (Japan), OMRON Corporation (Japan), Zenicor Medical Systems AB (Sweden), Longfian Scitech Co. Ltd (China)
Key Market Segmentation
Indication (Syncope, Arrhythmia, Other), End Use (Hospitals and Clinics, Home-Care, Ambulatory Surgical Centers (ASCs))
Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-single-lead-ecg-equipment-market
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-prurigo-nodularis-treatment-market
https://www.databridgemarketresearch.com/reports/global-mens-health-market
https://www.databridgemarketresearch.com/reports/global-adrenocorticotropic-hormone-acth-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com